Back
iShares 0-5 Year High Yield Corporate Bond ETF Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
35
SHYG
iShares 0-5 Year High Yield Corporate Bond ETF
Last Price:
$42.61
Seasonality Move:
-0.83%
Sell
2
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-6.74%
Sell
35
iShares 0-5 Year High Yield Corporate Bond ETF (SHYG)
is a Sell
Is iShares 0-5 Year High Yield Corporate Bond ETF a Buy, Sell or Hold?
-
The current iShares 0-5 Year High Yield Corporate Bond ETF [SHYG] share price is $42.62. The Score for SHYG is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
SHYG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
SHYG Stock Price Chart
What is iShares 0-5 Year High Yield Corporate Bond ETF's stock price today?
-
The iShares 0-5 Year High Yield Corporate Bond ETF share price today is $42.62Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SHYG is experiencing selling pressure, which indicates risk of future bearish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $40.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
SHYG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 43.25 | Sell |
Chaikin Money Flow: | -953558 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.59 - 43.07) | Sell |
Bollinger Bands (100): | (42.79 - 43.21) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 22.69 | Sell |
Chaikin Money Flow: | -2576687 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.5 - 57.26) | Sell |
Bollinger Bands (100): | (51.08 - 57.64) | Sell |
SHYG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.71 | Sell |
20-day SMA: | 42.76 | Sell |
50-day SMA: | 42.94 | Sell |
200-day SMA: | 42.61 | Buy |
8-day EMA: | 42.71 | Sell |
20-day EMA: | 42.77 | Sell |
50-day EMA: | 42.88 | Sell |
200-day EMA: | 42.65 | Sell |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.44 | Sell |
20-day SMA: | 52.35 | Sell |
50-day SMA: | 55.3 | Sell |
200-day SMA: | 51.01 | Sell |
8-day EMA: | 48.54 | Sell |
20-day EMA: | 51.52 | Sell |
50-day EMA: | 53.69 | Sell |
200-day EMA: | 49.87 | Sell |
iShares 0-5 Year High Yield Corporate Bond ETF Earnings Growth & SHYG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
iShares 0-5 Year High Yield Corporate Bond ETF Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |